171 related articles for article (PubMed ID: 17236813)
1. Clinical side effects during peripheral blood progenitor cell infusion.
Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
[TBL] [Abstract][Full Text] [Related]
2. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
Ozdemir E; Akgedik K; Akdogan S; Kansu E
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
[TBL] [Abstract][Full Text] [Related]
3. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
4. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
6. The effect of hematopoietic progenitor cells' temperature on cardiac arrhythmias in patients given peripheral blood progenitor cells.
Donmez A; Zoghi M; Cagirgan S; Acarlar C; Tombuloglu M
Transfus Apher Sci; 2006 Jun; 34(3):245-51. PubMed ID: 16931400
[TBL] [Abstract][Full Text] [Related]
7. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
[TBL] [Abstract][Full Text] [Related]
8. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients.
Martino M; Morabito F; Messina G; Irrera G; Pucci G; Iacopino P
Haematologica; 1996; 81(1):59-61. PubMed ID: 8900855
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
[TBL] [Abstract][Full Text] [Related]
10. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases.
Alessandrino P; Bernasconi P; Caldera D; Colombo A; Bonfichi M; Malcovati L; Klersy C; Martinelli G; Maiocchi M; Pagnucco G; Varettoni M; Perotti C; Bernasconi C
Bone Marrow Transplant; 1999 Mar; 23(6):533-7. PubMed ID: 10217182
[TBL] [Abstract][Full Text] [Related]
11. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
Sánchez-Salinas A; Cabañas-Perianes V; Blanquer M; Majado MJ; Insausti CL; Monserrat J; Sánchez-Ibáñez MV; Menchón P; García-Hernández A; Gómez-Espuch J; Morales A; Moraleda JM
Transfusion; 2012 Nov; 52(11):2382-6. PubMed ID: 22404870
[TBL] [Abstract][Full Text] [Related]
12. Severe vasospastic angina with hemodynamic compromise related to the infusion of dimethyl sulfoxide (DMSO)-cryopreserved autologous peripheral blood stem cells.
Bambace NM; Lachance S
Ann Hematol; 2013 Nov; 92(11):1571-2. PubMed ID: 23580150
[No Abstract] [Full Text] [Related]
13. Infusion technique of hematopoietic progenitor cells and related adverse events (CME).
Mulay SB; Greiner CW; Mohr A; Bryant SC; Lingineni RK; Padley D; Hogan WJ; Gastineau DA; Jacob EK
Transfusion; 2014 Aug; 54(8):1997-2003; quiz 1996. PubMed ID: 24697759
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
[TBL] [Abstract][Full Text] [Related]
15. Cardiac arrhythmia after infusion of cryopreserved stem cells.
Keung YK; Lau S; Elkayam U; Chen SC; Douer D
Bone Marrow Transplant; 1994 Sep; 14(3):363-7. PubMed ID: 7994256
[TBL] [Abstract][Full Text] [Related]
16. Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Otrock ZK; Beydoun A; Barada WM; Masroujeh R; Hourani R; Bazarbachi A
Haematologica; 2008 Mar; 93(3):e36-7. PubMed ID: 18310533
[TBL] [Abstract][Full Text] [Related]
17. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
[TBL] [Abstract][Full Text] [Related]
18. DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
Marcacci G; Corazzelli G; Becchimanzi C; Arcamone M; Capobianco G; Russo F; Frigeri F; Pinto A
Bone Marrow Transplant; 2009 Jul; 44(2):133-5. PubMed ID: 19182835
[No Abstract] [Full Text] [Related]
19. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide.
Abrahamsen JF; Rusten L; Bakken AM; Bruserud Ø
Transfusion; 2004 May; 44(5):785-9. PubMed ID: 15104663
[TBL] [Abstract][Full Text] [Related]
20. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
